Correction: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

Affiliations

¹ Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
² Department of Oncology, The First Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China.
³ Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
⁴ Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. caicunzhoudr@yeah.net.

^# Contributed equally.

Published Erratum

Ruoshuang Han et al. BMC Med. 2024.

. 2024 Sep 20;22(1):405.

doi: 10.1186/s12916-024-03644-0.

¹ Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
² Department of Oncology, The First Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China.
³ Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
⁴ Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. caicunzhoudr@yeah.net.

^# Contributed equally.

No abstract available

Erratum for

Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
Han R, Guo H, Shi J, Zhao S, Jia Y, Liu X, Liu Y, Cheng L, Zhao C, Li X, Zhou C. Han R, et al. BMC Med. 2024 Apr 24;22(1):174. doi: 10.1186/s12916-024-03389-w. BMC Med. 2024. PMID: 38658988 Free PMC article.

1. Han R, Guo H, Shi J, et al. Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer. BMC Med. 2024;22:174. 10.1186/s12916-024-03389-w. - PMC - PubMed